B. Braun Melsungen AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:B. Braun Melsungen AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010856
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
B. Braun Melsungen AG (B. Braun) is a global health care company. It offers products and solutions for therapy fields and applications including acute dialysis, infusion therapy, apheresis, interventional vascular, diagnostics and treatment, cardio-thoracic surgery, laparoscopy, degenerative spine surgery, neurosurgery, diabetes, nutrition therapy, general open surgery, orthopedic joint replacement, hemodialysis, pain therapy, incontinence, stoma, infection prevention, and wound management. It has manufacturing facilities and R&D centers in the US, Europe and Asia. The company sells its products through a network of subsidiaries and associated companies in Europe, the Americas, Asia-Pacific, Africa and the Middle East. B. Braun is headquartered in Melsungen, Germany.

B. Braun Melsungen AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
B. Braun Melsungen AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
B. Braun Melsungen AG, Medical Devices Deals, 2011 to YTD 2017 9
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
B. Braun Enters into Parntership with Royal Philip 11
Proxy Biomedical Extends Distribution Agreement with B. Braun Surgical 12
Kinetic Concepts Enters into Co-Marketing Agreement with B. Braun Medical for Prontosan 13
Yungjin Enters Into Distribution Agreement With B. Braun For Enteral Nutrition Products 14
Acquisition 15
B. Braun Medical Acquires Dismed Pharma and Dismed Criticare 15
B. Braun Medical Acquires Carenalis 16
B. Braun Avitum Acquires 51% Stake in Dialy Ser 17
B. Braun Melsungen Completes Acquisition Of Additional 3.02% Stake In Rhoen-Klinikum 18
B. Braun Singapore Completes Acquisition Of Majority Stake In Ahlcon Parenterals For US$48 Million 19
B. Braun Melsungen Acquires 5% Stake In Rhoen-Klinikum 21
B. Braun Melsungen Acquires Nutrichem diat+pharma From SSP 22
B. Braun Melsungen AG – Key Competitors 23
B. Braun Melsungen AG – Key Employees 24
B. Braun Melsungen AG – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 29
Recent Developments 31
Strategy And Business Planning 31
Dec 12, 2017: B. Braun establishes a subsidiary in Zambia 31
Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 32
Financial Announcements 33
Mar 31, 2017: B. Braun continues its sales and earnings growth 33
Mar 23, 2016: B. Braun’s growth trend continues 35
Corporate Communications 37
Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 37
Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 38
Feb 22, 2017: Change in the B. Braun Management Board 39
Oct 05, 2016: B. Braun Supports The International Safety Center 40
Other Significant Developments 41
Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 41
Feb 15, 2017: B. Braun Medical to Present Comprehensive Parenteral Nutrition Program at ASPEN’s Clinical Nutrition Week 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Key Facts, 2016 2
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
B. Braun Melsungen AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
B. Braun Melsungen AG, Deals By Therapy Area, 2011 to YTD 2017 8
B. Braun Melsungen AG, Medical Devices Deals, 2011 to YTD 2017 9
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
B. Braun Enters into Parntership with Royal Philip 11
Proxy Biomedical Extends Distribution Agreement with B. Braun Surgical 12
Kinetic Concepts Enters into Co-Marketing Agreement with B. Braun Medical for Prontosan 13
Yungjin Enters Into Distribution Agreement With B. Braun For Enteral Nutrition Products 14
B. Braun Medical Acquires Dismed Pharma and Dismed Criticare 15
B. Braun Medical Acquires Carenalis 16
B. Braun Avitum Acquires 51% Stake in Dialy Ser 17
B. Braun Melsungen Completes Acquisition Of Additional 3.02% Stake In Rhoen-Klinikum 18
B. Braun Singapore Completes Acquisition Of Majority Stake In Ahlcon Parenterals For US$48 Million 19
B. Braun Melsungen Acquires 5% Stake In Rhoen-Klinikum 21
B. Braun Melsungen Acquires Nutrichem diat+pharma From SSP 22
B. Braun Melsungen AG, Key Competitors 23
B. Braun Melsungen AG, Key Employees 24
B. Braun Melsungen AG, Other Locations 25
B. Braun Melsungen AG, Subsidiaries 25
B. Braun Melsungen AG, Joint Venture 29

★海外企業調査レポート[B. Braun Melsungen AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Finder Exploration Pty Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Finder Exploration Pty Ltd (Finder) is an oil and gas company that acquires and explores prospective acreage. The company offers acquisition of prospective acreage through drilling and detailed assessment and risk mitigation of exploration acreage. It holds exploration operations in Bedout S …
  • Japan Pulp and Paper Co Ltd:戦略・SWOT・企業財務分析
    Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The Prudential Insurance Company of America:企業のM&A・事業提携・投資動向
    The Prudential Insurance Company of America - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Prudential Insurance Company of America Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Tredegar Corp (TG):企業の財務・戦略的SWOT分析
    Tredegar Corp (TG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • EndoCeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary EndoCeutics Inc (EndoCeutics) is a pharmaceutical company that develops hormone sensitive cancer prevention therapies for women’s health. The company's pipeline product portfolio includes drugs for various indications such as endometriosis; male hypogonadism and antiandrogens, among others. …
  • Sisaf Ltd-医療機器分野:企業M&A・提携分析
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • Fukoku Mutual Life Insurance Company:企業の戦略・SWOT・財務情報
    Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Clevexel Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Clevexel Pharma SAS (Clevexel) is a drug development company that develops drugs to treat diseases of the central nervous system. The company’s pipeline product portfolio includes CVXL-0107, a glutamate release inhibitor developed to improve the quality of life for Parkinson’s disease patien …
  • China Chemical & Pharmaceutical Co Ltd (1701):企業の財務・戦略的SWOT分析
    China Chemical & Pharmaceutical Co Ltd (1701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • J.Crew Group, Inc.:企業の戦略・SWOT・財務情報
    J.Crew Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary J.Crew Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Avery Dennison Corporation (AVY)-医療機器分野:企業M&A・提携分析
    Summary Avery Dennison Corporation (Avery Dennison) is a labeling and packaging materials and solutions provider. The company produces pressure-sensitive materials, tags, labels, tickets, and other converted products. It also manufactures and sells fasteners, tickets, tags, radio-frequency identific …
  • Intermountain Healthcare Inc:企業の戦略的SWOT分析
    Intermountain Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Sentara Healthcare Inc:企業の戦略的SWOT分析
    Sentara Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Apollo Global Management Inc:企業の戦略・SWOT・財務分析
    Apollo Global Management Inc - Strategy, SWOT and Corporate Finance Report Summary Apollo Global Management Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Axpo Holding AG:企業の戦略的SWOT分析
    Axpo Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Edison SpA (EDNR):電力:M&Aディール及び事業提携情報
    Summary Edison SpA (Edison), a subsidiary of Electricite de France S.A., is an energy company that explores, produces, develops and sells natural gas and crude oil in the Mediterranean Basin. The company generates and sells electricity; and develops, stores, transports and sells gas in Italy. Edison …
  • Mediacom Communications Corporation:企業の戦略的SWOT分析
    Mediacom Communications Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Bruce Power LP:企業の戦略的SWOT分析
    Bruce Power LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Volvo Car Corporation:企業の戦略・SWOT・財務分析
    Volvo Car Corporation - Strategy, SWOT and Corporate Finance Report Summary Volvo Car Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NetSol Technologies, Inc. (NTWK):企業の財務・戦略的SWOT分析
    NetSol Technologies, Inc. (NTWK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆